OTA International · Nov 16, 2026
Perioperative antiplatelet use is not associated with increased risk of mortality among older adults undergoing operative hip fracture repair
By Akodu M, Rajesh D, Steele A et al.
Objectives: To assess whether perioperative antiplatelet use increases mortality risk among older adults undergoing operative hip fracture repair. Methods: Design: Retrospective study. Setting: Level 1 trauma center. Patient Selection Criteria: A total of 965 patients 65 years or older who underwent surgical fixation for hip fractures (OTA/OA 31A, 31B and 31C) between 2018 and 2023. Outcome Measures and Comparisons: The primary outcome was mortality at 365 days after discharge. Secondary outcomes were mortality at 30 days and 90 days, length of stay (LOS) > 7 days, need for blood transfusion, and 30-day readmission. Statistical Methods: Multivariate Cox proportional hazards models assessed the association between antiplatelet use and mortality. For secondary outcomes, a Firth penalized logistic regression model was used, correcting for potential confounders. RESULTS: The use of antiplatelet medications perioperatively was not significantly associated with mortality at 365 days, with adjusted hazard ratio (aHR) of 1.17, 95% confidence interval (CI) [0.76, 1.79] or at 30 days and 90 days, with aHRs of 0.94, 95% CI [0.44, 2.00] and 1.03, 95% CI [0.54, 1.97], respectively. There was a higher odds of being readmitted within 30 days of hospital discharge and getting a transfusion, with adjusted odds ratios (aORs) of 1.83, 95% CI [1.12, 3.00] and 1.60, 95% CI [1.00, 2.56], respectively, whereas there was no significant association with length of stay greater than 7 days, with aOR of 0.84, 95% CI [0.56, 1.26]. Conclusion: These findings indicate that undergoing hip fracture repair while on antiplatelet medications does not appear to confer a higher risk of mortality but may be correlated to higher readmission or transfusion rates. Level of Evidence: Therapeutic Level III.
doi.org/10.1097/oi9.0000000000000538PubMed 43042171Populations